Associations of triiodothyronine levels with carotid atherosclerosis and arterial stiffness in hemodialysis patients

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 9, 2011, Pages 2240-2246

  Tatar, Erhan ^a   Kircelli, Fatih ^a   Asci, Gulay ^a   Carrero, Juan Jesus ^b   Gungor, Ozkan ^a   Demirci, Meltem Sezis ^a   Ozbek, Suha Sureyya ^a   Ceylan, Naim ^a   Ozkahya, Mehmet ^a   Toz, Huseyin ^a   Ok, Ercan ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; ERYTHROPOIETIN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROID HORMONE; THYROTROPIN; THYROXINE; VITAMIN D;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTERY MEDIA; ARTICLE; AUGMENTATION INDEX; BLOOD VESSEL CALCIFICATION; CAROTID ARTERY INTIMA MEDIA THICKNESS; CAROTID ATHEROSCLEROSIS; CAROTID FEMORAL PULSE WAVE VELOCITY; CHEMOLUMINESCENCE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; DIABETIC PATIENT; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; FEMALE; FREE LIOTHYRONINE INDEX; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOASSAY; INTIMA; LIOTHYRONINE BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PULSE WAVE; SCORING SYSTEM; SPHYGMOMANOMETER; SYSTOLIC BLOOD PRESSURE; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; WEIGHT GAIN;

CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; TRIIODOTHYRONINE; VASCULAR CALCIFICATION; VASCULAR STIFFNESS;

EID: 80052605638     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02540311     Document Type: Article

References (35)

1. Lo JC, Chertow GM, Go AS, Hsu CY: Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int 67: 1047-1052, 2005
2. Chonchol M, Lippi G, Salvagno G, Zoppini G, Muggeo M, Targher G: Prevalence of subclinical hypothyroidism in patients with chronic kidney disease. Clin J Am Soc Nephrol 3: 1296-1300, 2008
3. Lim VS: Thyroid function in patients with chronic renal failure. Am J Kidney Dis 38: 80-84, 2001
4. Song SH, Kwak IS, Lee DW, Kang YH, Seong EY, Park JS: The prevalence of low triiodothyronine according to the stage of chronic kidney disease in subjects with a normal thyroidstimulating hormone. Nephrol Dial Transplant 24: 1534-1538, 2009
5. Ozen KP, Asci G, Gungor O, Carrero JJ, Kircelli F, Tatar E, Ok Sevinc E, Ozkahya M, Toz H, Cirit M, Basci A, Ok E: Nutritional state alters the association between free triiodothyronine levels and mortality in hemodialysis patients. Am J Nephrol 33: 305-312, 2011
6. Zoccali C, Tripepi G, Cutrupi S, Pizzini P, Mallamaci F: Low triiodothyronine: A new facet of inflammation in end-stage renal disease. J Am Soc Nephrol 16: 2789-2795, 2005
7. Carrero JJ, Qureshi AR, Axelsson J, Yilmaz MI, Rehnmark S, Witt MR, Bárány P, Heimbürger O, Suliman ME, Alvestrand A, Lindholm B, Stenvinkel P: Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease. J Intern Med 262: 690-701, 2007
8. Disthabanchong S, Treeruttanawanich A: Oral sodium bicarbonate improves thyroid function in predialysis chronic kidney disease. Am J Nephrol 32: 549-556, 2010
9. Ojamaa K, Klemperer JD, Klein I: Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 6: 505-512, 1996
10. Napoli R, Biondi B, Guardasole V, Matarazzo M, Pardo F, Angelini V, Fazio S, Sacca L: Impact of hyperthyroidism and its correction on vascular reactivity in humans. Circulation 104: 3076-3080, 2001
11. Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, Salvetti A, Ferrannini E, Monzani F: Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: Beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 88: 3731-3737, 2003
12. Fukuyama K, Ichiki T, Takeda K, Tokunou T, Iino N, Masuda S, Ishibashi M, Egashira K, Shimokawa H, Hirano K, Kanaide H, Takeshita A: Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone. Hypertension 41: 598-603, 2003
13. Vanhaelst L, Neve P, Chailly P, Bastenie PA: Coronary-artery disease in hypothyroidism: Observations in clinical myxoedema. Lancet 2: 800-802, 1967
14. Nagasaki T, Inaba M, Henmi Y, Kumeda Y, Ueda M, Tahara H, Sugiguchi S, Fujiwara S, Emoto M, Ishimura E, Onoda N, Ishikawa T, Nishizawa Y: Decrease in carotid intima-media thickness in hypothyroid patients after normalization of thyroid function. Clin Endocrinol 59: 607-612, 2003
15. Rodondi N, Newman AB, Vittinghoff E, de Rekeneire N, Satterfield S, Harris TB, Bauer DC: Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 165: 2460-2466, 2005
16. Zoccali C, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P: Low triiodothyronine and survival in end-stage renal disease. Kidney Int 70: 523-528, 2006
17. Yilmaz MI, Sonmez A, Karaman M, Ay SA, Saglam M, Yaman H, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M, Zoccali C: Low triiodothyronine alters flow-mediated vasodilatation in advanced nondiabetic kidney disease. Am J Nephrol 33: 25-32, 2011
18. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972
19. Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, Cockcroft JR, Webb DJ: Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 16: 2079-2084, 1998
20. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R: Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15: 827-832, 1990
21. Morris MS, Bostom AG, Jacques PF, Selhub J, Rosenberg IH: Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey. Atherosclerosis 155: 195-200, 2001
22. Christ-Crain M, Meier C, Guglielmetti M, Huber PR, Riesen W, Staub JJ, Müller B: Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis 166: 379-386, 2003
23. Chadarevian R, Bruckert E, Leenhardt L, Giral P, Ankri A, Turpin G: Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J Clin Endocrinol Metab 86: 732-737, 2001
24. Papagianni A, Kalovoulos M, Kirmizis D, Vainas A, Belechri AM, Alexopoulos E, Memmos D: Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients. Nephrol Dial Transplant 18: 113-119, 2003
25. Zoccali C, Benedetto F, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P, Malatino LS, Bonanno G, Seminara G: Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease. J Hypertension 24: 2039-2046, 2006
26. Costantini F, Pierdomenico SD, De Cesare D, De Remigis P, Bucciarelli T, Bittolo-Bon G, Cazzolato G, Nubile G, Guagnano MT, Sensi S, Cuccurullo F, Mezzetti A: Effect of thyroid function on LDL oxidation. Arterioscler Thromb Vasc Biol 18: 732-737, 1998
27. Fukuyama K, Ichiki T, Imayama I, Ohtsubo H, Ono H, Hashiguchi Y, Takeshita A, Sunagawa K: Thyroid hormone inhibits vascular remodeling through suppression of cAMP response element binding protein activity. Arterioscler Thromb Vasc Biol 26: 2049-2055, 2006
28. London GM, Marchais SJ, Guerin AP, Metivier F, Adda H: Arterial structure and function in end-stage renal disease. Nephrol Dial Transplant 17: 1713-1724, 2002
29. Nagasaki T, Inaba M, Kumeda Y, Hiura Y, Shirakawa K, Yamada S, Henmi Y, Ishimura E, Nishizawa Y: Increased pulse wave velocity in subclinical hypothyroidism. J Clin Endocrinol Metab 91: 154-158, 2006
30. Isumi Y, Shoji H, Sugo S, Tochimoto T, Yoshioka M, Kangawa K, Matsuo H, Minamino N: Regulation of adrenomedullin production in rat endothelial cells. Endocrinology 139: 838-846, 1998
31. Davis FB, Mousa SA, O'Connor L, Mohamed S, Lin HY, Cao HJ, Davis PJ: Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. Circ Res 94: 1500-1506, 2004
32. Gogakos AI, Duncan Bassett JH, Williams GR: Thyroid and bone. Arch Biochem Biophys 503: 129-136, 2010
33. Sato Y, Nakamura R, Satoh M, Fujishita K, Mori S, Ishida S, Yamaguchi T, Inoue K, Nagao T, Ohno Y: Thyroid hormone targets matrix Gla protein gene associated with vascular smooth muscle calcification. Circ Res 97: 550-557, 2005
34. Floege J, Ketteler M: Vascular calcification in patients with end-stage renal disease. Nephrol Dial Transplant 19: 59-66, 2004
35. Moe SM, O'Neill KD, Reslerova M, Fineberg N, Persohn S, Meyer CA: Natural history of vascular calcification in dialysis and transplant patients. Nephrol Dial Transplant 19: 2387-2393, 2004